What stays known
The operating platform
- Current Brickell gel cleanser base
- Existing compounding and fill family
- Current exact 3.4 oz / 100 mL operating format
- Existing modular active-addition precedent
Daily Face Wash · Working product decision
Use the cleanser Brickell already knows how to make.
Keep the current gel platform, give it an Acadia scent, and use the existing hyaluronic-acid version as the first product candidate. That is a controlled adaptation—not months of new cleanser development.
Confirmed in current Odoo evidence
Recommended Acadia direction
Exact release held
Recommended low-development route
Same gel base. Existing HA add-in. New scent.
Current Brickell records show both the regular Clarifying Gel Face Wash and another active face wash that already combines the same gel base, an existing hyaluronic-acid serum, and a separately added scent.
What becomes Acadia
The customer experience
- Quiet cedar / green citrus scent
- Hyaluronic-acid ingredient story
- Morning + night timing role
- Mineral-white Acadia package in the Edge of Day visual world
Three fast bench choices
One control, one recommendation, one challenger.
Joe controls the exact formula and process. These are the three questions worth answering—not an open-ended R&D program.
A · Fastest fallback
Scent change only
Current gel base plus the new Acadia fragrance. If the other additions cause trouble, this preserves the fastest launch route.
B · Recommended
Existing HA architecture
Use the same base + existing hyaluronic-acid serum structure Brickell already runs, then change only the scent.
C · Only if worth it
Niacinamide + B5
A recognizable alternative story, but it creates more formulation work. It should not delay Batch B unless marketing expects a material benefit.
Working five-product platform map
Four intended unchanged platforms. One controlled cleanser adaptation.
The goal is not to sprinkle ingredients into everything. Keep a selected formula unchanged only after its controlled identity, rights, specification, and INCI are reconciled; change a package, scent, or one controlled input only when the commercial value is real.
01
AM + PM
Daily Face Wash
Current gel cleanser platform and current HA-serum add-in precedent.
Acadia change
New quiet cedar / green citrus scent; existing HA architecture is the recommended bench candidate.
Short adaptation
Keep scent-only as fallback.
02
AM
Vitamin C Serum
Current unscented Repairing Vitamin C route.
Acadia change
Intend to change package and brand only in a working 15 mL pack. The current internal analog contains sodium ascorbyl phosphate and an HA-solution input; exact operating identity, rights, stability, INCI, and customer claims remain held.
Unchanged candidate
Controlled identity and claims held.
03
AM
Daily Moisturizer
Current unscented moisturizer-platform candidate; the operating bulk record is misnamed and has no active formula BoM in the current snapshot.
Acadia change
Intend to move the existing bulk into a working 30 mL pack without formula changes, but only after Joe retrieves and reconciles the controlled bulk specification, master formula, rights, and INCI.
Platform candidate
Dossier reconciliation and package trial required.
04
PM · Every other night
Retinol Serum
Current unscented Retinol Facial Serum route; introduce gradually before the working alternating-night schedule.
Acadia change
Intend to use the existing formula unchanged in a working 15 mL pack designed to meet the released light, oxygen, compatibility, and dispense requirements. Retinoid identity and strength are formula-defining—not sprinkle-in territory.
Unchanged candidate
Working every-other-night use; identity, strength, dose, warnings, and pack held.
05
PM
Night Face Cream
Current richer unscented cream-platform candidate.
Acadia change
Intend to use the richer unscented route unchanged in a working 30 mL pack after Joe reconciles the controlled identity, rights, specification, and INCI. Confirm whether the formula supports “fragrance-free” before using that term.
Platform candidate
Dossier reconciliation, tube dispense, and evacuation required.
Current evidence boundary: These are working source-platform selections from read-only Odoo BoMs and manufacturing history. They are not Acadia formula releases. Joe/Product must confirm the controlled RP/RT identities, exact specifications, rights, process, package fit, testing, labeling, claims, and final fills.
Working sell story
Product proof without ingredient theater.
Morning + night
Daily Face Wash
A clear gel-cleanser candidate with an existing hyaluronic-acid add-in precedent, assigned to the working first slot in both the morning and evening routes.
Working copy only: The exact Acadia formula, sensory result, directions, ingredient list, and claims still require Product/Quality release.
ACADIA · EDGE OF DAYMORNING + NIGHT
100 · 15 · 30 · 15 · 30 mL
The plan consolidates the working quantities for the period into one shipment. Final quantities and container forms remain held.
What Joe actually needs to answer
A short controlled adaptation—not a blank sheet.
01Confirm the controlled baseResolve the current RT/RP formula-code relationship and pull the released specification.
02Bench the three candidatesCompare pH, viscosity, clarity, odor, foam, rinse, afterfeel, and pumpability.
03Reject quicklyDrop any version that meaningfully moves the base or creates process/dispense trouble.
04Release the winner correctlyRun the Quality-approved stability, micro/preservation, package, line, safety, and claim review.
Rule for all five products
Use the closest current operating platform. Change only what earns its complexity.
Vitamin C and retinol are formula-defining, so the intent is to keep the selected operating routes unchanged while Joe reconciles them to controlled formula records. The moisturizer and night cream are also intended unchanged, but their controlled identity, rights, specification, and INCI must be reconciled before package qualification can release them.
Next product task
Build one five-row platform map: exact current analog, bulk/formula identity, existing package/process, current evidence, proposed Acadia change, and estimated release burden. Unknowns stay blank.